{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T20:48:49Z","timestamp":1768769329656,"version":"3.49.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Gastrointestinal large cell neuroendocrine carcinoma (GILCNEC) has a low incidence but high malignancy and poor prognosis. The main purpose of this study was to thoroughly investigate its clinicopathological features, survival and prognostic factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Information on patients with GILCNEC was extracted from the Surveillance, Epidemiology, and End Result program, and prognostic factors were analyzed by analyzing clinicopathological data and survival functions. Finally, multivariate analysis was applied to identify independent risk factors associated with survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 531 individuals were screened in our study from the Surveillance, Epidemiology, and End Result database. The primary sites are mainly from the following: esophagus in 39 (7.3%) patients, stomach in 72 (13.6%) patients, hepatobiliary in 51 (9.6%) patients, pancreas in 97 (18.3%) patients, small intestines in 27 (5.1%), and colorectum in 245 (46.1%) patients. Esophagus, stomach, pancreas, and colorectum large cell neuroendocrine carcinoma (LCNEC) were more common in males (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). Esophagus LCNEC had inferior overall survival (OS), whereas small intestine LCNEC was associated with better OS. The results of multivariate analysis showed that the American Joint Committee on Cancer Sixth Edition stage, surgery, and radiotherapy were independent prognostic indicators of OS in patients with GILCNEC (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The prognosis of patients with GILCNEC varies depending on the primary tumor site. American Joint Committee on Cancer Sixth Edition stage, surgery, and radiotherapy are independent prognostic factors of patients with GILCNEC. Although surgery and radiotherapy can prolong the survival of patients with GILCNEC, their prognosis remains poor, and further prospectively designed multicenter clinical studies are needed to indicate the decision for clinicians.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000001104","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:01:32Z","timestamp":1713355292000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Lele","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Quzhou People\u2019s Hospital, Quzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory Department, Mental Health Institute of Inner Mongolia Autonomous Region, The Third Hospital of Inner Mongolia Autonomous Region, Hohhot, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"e2124750","DOI":"10.1001\/jamanetworkopen.2021.24750","article-title":"Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdx193","article-title":"Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study","volume":"28","author":"Pavel","year":"2017","journal-title":"Ann Oncol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mtc.2002.119886","article-title":"Bronchial carcinoid tumors: surgical management and long-term outcome","volume":"123","author":"Filosso","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.path.2020.04.002","article-title":"Diagnosis and management of gastrointestinal neuroendocrine neoplasms","volume":"13","author":"Gonzalez","year":"2020","journal-title":"Surg Pathol Clin"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2009.12.011","article-title":"Large cell\/neuroendocrine carcinoma","volume":"69","author":"Gollard","year":"2010","journal-title":"Lung Cancer"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijscr.2020.10.015","article-title":"Large cell neuroendocrine carcinoma of the colon with brain metastasis: a case report","volume":"76","author":"Allouch","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000489295","article-title":"Esophageal large-cell neuroendocrine carcinoma with inconsistent response to treatment in the primary and metastatic lesions","volume":"12","author":"Tomiyama","year":"2018","journal-title":"Case Rep Gastroenterol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5858\/2003-127-221-LCNCOT","article-title":"Large cell neuroendocrine carcinoma of the ampulla of vater","volume":"127","author":"Cavazza","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.ejca.2012.12.022","article-title":"Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry","volume":"49","author":"Korse","year":"2013","journal-title":"Eur J Cancer"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/j.gastro.2007.01.006","article-title":"Survival from malignant digestive endocrine tumors in England and Wales: a population-based study","volume":"132","author":"Lepage","year":"2007","journal-title":"Gastroenterology"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4143\/crt.2012.44.3.157","article-title":"Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study","volume":"44","author":"Cho","year":"2012","journal-title":"Cancer Res Treat"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"653162","DOI":"10.3389\/fonc.2021.653162","article-title":"Management of large cell neuroendocrine carcinoma","volume":"11","author":"Corbett","year":"2021","journal-title":"Front Oncol"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/dc.22872","article-title":"Endoscopic ultrasound-guided fine-needle aspiration diagnosis of large cell neuroendocrine carcinoma of the gallbladder and common bile duct: report of a case","volume":"41","author":"Samad","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"18048","DOI":"10.3748\/wjg.v20.i47.18048","article-title":"Primary large cell neuroendocrine carcinoma in the common bile duct: first Asian case report","volume":"20","author":"Park","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/pgmj.2008.070649","article-title":"Neuroendocrine tumours of the gallbladder: three cases and a review of the literature","volume":"85","author":"Iype","year":"2009","journal-title":"Postgrad Med J"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3109\/0284186X.2014.941999","article-title":"Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms","volume":"53","author":"Janson","year":"2014","journal-title":"Acta Oncol"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","article-title":"The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas","volume":"39","author":"Strosberg","year":"2010","journal-title":"Pancreas"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1245\/s10434-015-5013-2","article-title":"Surgical treatment as a principle for patients with high-grade pancreatic neuroendocrine carcinoma: a Nordic multicenter comparative study","volume":"23","author":"Haugvik","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3748\/wjg.v23.i3.516","article-title":"Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas","volume":"23","author":"Liu","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-020-08730-0","article-title":"Impact of postoperative chemotherapy on the survival of patients with high-grade gastroenteropancreatic neuroendocrine carcinoma","volume":"28","author":"Schmitz","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000518873","article-title":"NETest: a systematic review focusing on the prognostic and predictive role","volume":"112","author":"Puliani","year":"2022","journal-title":"Neuroendocrinology"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:00:16Z","timestamp":1748365216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001104"}},"subtitle":["A Retrospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001104","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}